Betaine and nonalcoholic steatohepatitis

Back to the future?

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Nonalcoholic steatohepatitis (NASH) is an important indication for liver transplantation in many Western countries. Obesity and insulin resistance are the two most common risk factors for NASH, which can lead to recurrent NASH after liver transplantation. There is currently no approved therapy for NASH, and treatment is directed at risk factor modifcation and lifestyle changes. Betaine has been used for NASH, with mixed results, and may show promise in conjunction with other agents in clinical trials.

Original languageEnglish
Pages (from-to)3663-3664
Number of pages2
JournalWorld Journal of Gastroenterology
Volume17
Issue number32
DOIs
StatePublished - Aug 28 2011
Externally publishedYes

Fingerprint

Betaine
Liver Transplantation
Insulin Resistance
Life Style
Obesity
Non-alcoholic Fatty Liver Disease
Clinical Trials
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Betaine and nonalcoholic steatohepatitis : Back to the future? / Mukherjee, Sandeep.

In: World Journal of Gastroenterology, Vol. 17, No. 32, 28.08.2011, p. 3663-3664.

Research output: Contribution to journalArticle

@article{bbc1ecdc154d4278baa982f4e07bd48f,
title = "Betaine and nonalcoholic steatohepatitis: Back to the future?",
abstract = "Nonalcoholic steatohepatitis (NASH) is an important indication for liver transplantation in many Western countries. Obesity and insulin resistance are the two most common risk factors for NASH, which can lead to recurrent NASH after liver transplantation. There is currently no approved therapy for NASH, and treatment is directed at risk factor modifcation and lifestyle changes. Betaine has been used for NASH, with mixed results, and may show promise in conjunction with other agents in clinical trials.",
author = "Sandeep Mukherjee",
year = "2011",
month = "8",
day = "28",
doi = "10.3748/wjg.v17.i32.3663",
language = "English",
volume = "17",
pages = "3663--3664",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "32",

}

TY - JOUR

T1 - Betaine and nonalcoholic steatohepatitis

T2 - Back to the future?

AU - Mukherjee, Sandeep

PY - 2011/8/28

Y1 - 2011/8/28

N2 - Nonalcoholic steatohepatitis (NASH) is an important indication for liver transplantation in many Western countries. Obesity and insulin resistance are the two most common risk factors for NASH, which can lead to recurrent NASH after liver transplantation. There is currently no approved therapy for NASH, and treatment is directed at risk factor modifcation and lifestyle changes. Betaine has been used for NASH, with mixed results, and may show promise in conjunction with other agents in clinical trials.

AB - Nonalcoholic steatohepatitis (NASH) is an important indication for liver transplantation in many Western countries. Obesity and insulin resistance are the two most common risk factors for NASH, which can lead to recurrent NASH after liver transplantation. There is currently no approved therapy for NASH, and treatment is directed at risk factor modifcation and lifestyle changes. Betaine has been used for NASH, with mixed results, and may show promise in conjunction with other agents in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=80053910713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053910713&partnerID=8YFLogxK

U2 - 10.3748/wjg.v17.i32.3663

DO - 10.3748/wjg.v17.i32.3663

M3 - Article

VL - 17

SP - 3663

EP - 3664

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 32

ER -